Differential spindle assembly checkpoint response in human lung adenocarcinoma cells

Cell and Tissue Research

Volumn 300, Issue 1, 2000, Pages 57-65

  Weitzel, Douglas H ^a   Vandré, Dale D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; CI 980; Human; Microtubule inhibitors; Mitosis; Multinucleation

Indexed keywords

COLCHICINE; MIVOBULIN ISETHIONATE; NOCODAZOLE; PACLITAXEL; TUBULIN;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL POPULATION; CONTROLLED STUDY; DEPOLYMERIZATION; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; MULTINUCLEAR CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBAMATES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GIANT CELLS; HUMANS; LUNG NEOPLASMS; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; PYRAZINES; PYRIDINES; TUMOR CELLS, CULTURED;

EID: 0034037094     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004410050047     Document Type: Article

References (29)

1. Andreassen PR, Margolis RL (1994) Microtubule dependency of p34-cdc2 inactivation and mitotic exit in mammalian cells. J Cell Biol 127:789-802
2. Barbier P, Peyrot V, Dumortier C, D'Hoore A, Rener G, Engelborghs Y (1996) Kinetics of association and dissociation of two enantiomers, NSC 613863 (R)-(+) and NSC 613862 (S)-(-) (CI-980), to tubulin. Biochemistry 35:2008-2015
3. Bowdon BJ, Waud WR, Wheeler GP, Hain R, Dansby L, Temple C (1987) Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis. Cancer Res 47:1621-1626
4. Cahill DP, Lengauer C, Yu J, Riggins GJ, Wilson JKV, Markowitz SD, Kinzler KW, Vogelstein B (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392:300-303
5. Ding M, Feng Y, Vandré DD (1997) Partial characterization of the MPM-2 phosphoepitope. Exp Cell Res 231:3-13
6. Farr KA, Hoyt MA (1998) Bub1p kinase activates the Saccharomyces cerevisiae spindle assembly checkpoint. Mol Cell Biol 18:2738-2747
7. Hartwell L (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546
8. Hartwell LH, Weinert TA (1989) Checkpoints: controls that ensure the order of cell cycle events. Science 246:629-634
9. Hook KE, Przybranowski SA, Leopold WR (1996) Cellular transport of CI-980. Invest New Drugs 14:341-347
10. Ines C de, Leynadier D, Barasoain I, Peyrot V, Garcia P, Briand C, Rener G, Temple C (1994) Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI-980, and by its chiral isomer, NSC 613863. Cancer Res 54:75-84
11. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L (1996) Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56:816-825
12. Kudelka AP, Hasenburg A, Verschraegen CF, Edwards CL, Meyers CA, Varma D, Freedman RS, Forman A, Conrad CA, Grove W, Grothey A, Kavanagh JJ (1998) Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinoma. Anticancer Drugs 9:405-409
13. Kuriyama R (1982) Effect of colcemid on the centriole cycle in Chinese hamster ovary cells. J Cell Sci 53:155-171
14. Li Y, Benezra R (1996) Identification of a human mitotic checkpoint gene: hsMAD2. Science 274:246-248
15. L and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 10: 2621-2631
16. Mitchell CE, Belinsky SA, Lechner JF (1995) Detection and quantitation of mutant K-ras codon 12 restriction fragments by capillary electrophoresis. Anal Biochem 224:148-153
17. Patel S R, Burgess MA, Papadopolous NE, Sidhu G, Gray R, Plager C, Jenkins J, Benjamin RS (1998) Phase II study of CI-980 in patients with previously treated advanced soft-tissue sarcomas. Invest New Drugs 16:87-92
18. Rieder CL, Cole RW, Khodjakov A, Sluder G (1995) The checkpoint delaying anaphase in response to chromosome mono-orientation is mediated by an inhibitory signal produced by unattached kinetochores. J Cell Biol 130:941-948
19. Rowinsky EK, Noe DA, Grochow LB, Bowling MK, Sartorious SE, O'Reilly S, Chen T-L, Donehower RC (1995) Phase I and pharmacological study of CI-980, a synthetic and structurally unique antimicrotubule agent, on a 72-hour continuous infusion schedule in adults with solid tumors. Proc Am Soc Clin Oncol 14:459
20. Rudner AM, Murray AW (1996) The spindle assembly checkpoint. Curr Opin Cell Biol 8:773-780
21. Schiff PB, Horowitz SB (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77:1561-1565
22. Sherwood SW, Sheridan JP, Schimke RT (1994) Induction of apoptosis by the antitubulin drug colcemid: relationship of mitotic checkpoint control to the induction of apoptosis in HeLa S3 cells. Exp Cell Res 215:373-379
23. Sklarin NT, Benson L, Roca J, Einzig AI, Wiernik PH, Whitfield LR, Lathia C, Kowal C, Grove W (1995) Phase I study of CI-980: 24-hr infusion schedule. Proc Am Soc Clin Oncol 14:479
24. Taylor SS, McKeon F (1997) Kinetochore localization of murine bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89:727-735
25. Thomas JP, Moore T, Kraut EH, Balcerzak SP (1999) A phase II study of CI-980 in previously untreated small-cell lung cancer: an Ohio State University consortium study. Clin Cancer Res 5:223
26. Wells WAE (1996) The spindle-assembly checkpoint: aiming for a perfect mitosis, every time. Trends Cell Biol 6:228-234
27. Wheeler GP, Bowdon BJ, Werline JA, Temple C (1981) 1-Deaza-7,8-dihydropterdines, a new class of mitotic inhibitors with anticancer activity. Biochem Pharmacol 30:2381-2384
28. 2/M transition: abrupt breakdown of cytoplasmic microtubules at nuclear envelope breakdown and implications for spindle morphogenesis. J Cell Biol 135:201-214
29. Zieve GW, Turnbull D, Mullins JM, McIntosh JR (1980) Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Exp Cell Res 126:397-405